Related Experiment Videos
[Selection of a prosthetic valve for mitral valve replacement]
1Second Department of Surgery, Kurume University School of Medicine, Japan.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai
|March 1, 1990
Summary
The St. Jude Medical (SJM) prosthesis demonstrated superior long-term durability and safety compared to porcine bioprosthesis (P-B) in mitral valve replacement patients. SJM is recommended for mitral valve procedures due to better freedom from prosthetic valve dysfunction.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Prosthetic Devices
Context:
- Mitral valve replacement is a critical procedure for managing severe mitral valve disease.
- Selecting the appropriate prosthetic valve is crucial for long-term patient outcomes.
- This study retrospectively evaluates early and late results of two prosthetic valve types.
Purpose:
- To compare the clinical outcomes of St. Jude Medical (SJM) mechanical prosthesis and porcine bioprosthesis (P-B) in mitral valve replacement.
- To determine the optimal prosthetic valve selection for the mitral position based on long-term performance.
- To assess survival rates, valve-related death, thromboembolic complications, and prosthetic valve dysfunction.
Summary:
- A retrospective analysis compared SJM (n=341) and P-B (n=102) mitral valve replacements (1975-1987).
- Operative mortality and survival rates were comparable, but SJM showed significantly better freedom from prosthetic valve dysfunction, especially after seven years.
- Thromboembolic events and valve-related deaths were similar between groups.
Impact:
- The St. Jude Medical prosthesis is identified as a suitable and durable option for mitral valve replacement.
- Findings guide prosthetic valve selection, potentially improving long-term patient outcomes and reducing reoperation rates.
- This research contributes to evidence-based practice in cardiac valve surgery.